Table 3 Changes in biochemical parameters in the ES (n = 10), EX (n = 10), and SED (n = 10) groups
Parameter | Mean ± SE | Time* (p value) | Repeated measures ANOVA† (p value) | |
|---|---|---|---|---|
Baseline | 12 weeks | |||
Kt/V | ||||
ES | 1.3 ± 0.0 | 1.5 ± 0.0 | 0.01 | Group 0.04 |
EX | 1.3 ± 0.0 | 1.5 ± 0.0 | 0.02 | Time 0.01 |
SED | 1.3 ± 0.0 | 1.3 ± 0.0 | 0.47 | Interaction 0.65 |
Group‡ (p value) | 0.23 | 0.04 | ||
BUN (mg/dl) | ||||
ES | 6.7 ± 0.3 | 5.5 ± 0.1 | 0.35 | Group 0.93 |
EX | 5.5 ± 0.1 | 5.0 ± 0.3 | 0.58 | Time 0.49 |
SED | 6.2 ± 0.5 | 6.3 ± 0.8 | 0.33 | Interaction 0.95 |
Group‡ (p value) | 0.977 | 0.908 | ||
Phosphorus (mg/dl) | ||||
ES | 6.0 ± 0.0 | 4.7 ± 0.1 | 0.04 | Group 0.04 |
EX | 5.3 ± 0.1 | 5.1 ± 0.1 | 0.52 | Time 0.04 |
SED | 4.7 ± 0.1 | 5.4 ± 0.1 | 0.50 | Interaction 0.43 |
Group‡ (p value) | 0.39 | 0.59 | ||
Potassium (mEq/l) | ||||
ES | 5.3 ± 0.1 | 5.0 ± 0.0 | 0.08 | Group 0.93 |
EX | 4.8 ± 0.1 | 4.6 ± 0.2 | 0.88 | Time 0.74 |
SED | 4.7 ± 0.1 | 4.8 ± 0.1 | 0.96 | Interaction 0.63 |
Group‡ (p value) | 0.55 | 0.59 | ||
Alb (g/dl) | ||||
ES | 3.6 ± 0.0 | 3.5 ± 0.0 | 0.58 | Group 0.72 |
EX | 3.4 ± 0.1 | 3.5 ± 0.0 | 0.55 | Time 0.95 |
SED | 3.6 ± 0.0 | 3.6 ± 0.0 | 0.80 | Interaction 0.07 |
Group‡ (p value) | 0.69 | 0.91 | ||
Hb (g/dl) | ||||
ES | 10.4 ± 0.1 | 10.3 ± 0.1 | 0.91 | Group 0.21 |
EX | 10.8 ± 0.1 | 10.3 ± 0.1 | 0.41 | Time 0.49 |
SED | 11.0 ± 0.1 | 11.0 ± 0.1 | 0.91 | Interaction 0.77 |
Group‡ (p value) | 0.766 | 0.309 | ||
Fer (ng/ml) | ||||
ES | 118.9 ± 11.9 | 181.4 ± 15.9 | 0.24 | Group 0.10 |
EX | 133.7 ± 11.9 | 179.3 ± 17.4 | 0.11 | Time 0.07 |
SED | 84.5 ± 3.8 | 91.1 ± 6.1 | 0.79 | Interaction 0.43 |
Group‡ (p value) | 0.43 | 0.20 | ||
TSAT (%) | ||||
ES | 22.6 ± 0.5 | 24.7 ± 0.8 | 0.48 | Group 0.09 |
EX | 21.9 ± 0.5 | 24.8 ± 0.6 | 0.50 | Time 0.07 |
SED | 23.5 ± 0.9 | 26.5 ± 1.0 | 0.53 | Interaction 0.43 |
Group‡ (p value) | 0.90 | 0.89 | ||
HDL-C (mg/dl) | ||||
ES | 50.6 ± 1.1 | 47.9 ± 0.7 | 0.03 | Group 0.16 |
EX | 43.2 ± 0.8 | 45.1 ± 1.2 | 0.03 | Time 0.04 |
SED | 43.2 ± 1.3 | 43.4 ± 1.1 | 0.13 | Interaction 0.69 |
Group‡ (p value) | 0.27 | 0.47 | ||
LDL-C/HDL-C | ||||
ES | 1.8 ± 0.1 | 1.9 ± 0.1 | 0.39 | Group 0.52 |
EX | 2.0 ± 0.1 | 2.0 ± 0.1 | 0.58 | Time 0.22 |
SED | 2.1 ± 0.0 | 2.2 ± 0.1 | 0.37 | Interaction 0.87 |
Group‡ (p value) | 0.51 | 0.79 | ||
CRP (mg/dl) | ||||
ES | 0.4 ± 0.1 | 0.3 ± 0.1 | 0.47 | Group 0.41 |
EX | 0.7 ± 0.1 | 0.4 ± 0.1 | 0.04 | Time 0.04 |
SED | 0.2 ± 0.0 | 0.2 ± 0.0 | 0.70 | Interaction 0.75 |
Group‡ (p value) | 0.46 | 0.80 | ||
IL-6 (pg/mL) | ||||
ES | 6.7 ± 0.2 | 6.9 ± 0.5 | 0.89 | Group 0.61 |
EX | 4.4 ± 0.2 | 4.6 ± 0.2 | 0.48 | Time 0.25 |
SED | 5.4 ± 0.3 | 6.5 ± 0.4 | 0.14 | Interaction 0.93 |
Group‡ (p value) | 0.38 | 0.55 | ||
TNF-α (pg/ml) | ||||
ES | 6.7 ± 0.3 | 4.5 ± 0.1 | 0.04 | Group 0.23 |
EX | 6.5 ± 1.0 | 7.0 ± 0.3 | 0.04 | Time 0.04 |
SED | 6.2 ± 0.5 | 9.3 ± 0.8 | 0.03 | Interaction 0.32 |
Group‡ (p value) | 0.40 | 0.03 | ||